Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$16.95 - $27.04 $13.2 Million - $21.1 Million
780,180 New
780,180 $21.1 Million
Q4 2023

Feb 14, 2024

BUY
$6.29 - $15.72 $271,218 - $677,830
43,119 New
43,119 $529,000
Q3 2022

Nov 14, 2022

BUY
$36.98 - $49.2 $5.83 Million - $7.76 Million
157,681 New
157,681 $7.1 Million
Q2 2022

Aug 15, 2022

SELL
$28.03 - $45.8 $8.07 Million - $13.2 Million
-288,072 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$29.24 - $44.06 $8.42 Million - $12.7 Million
288,072 New
288,072 $11.9 Million
Q2 2021

Aug 16, 2021

SELL
$44.66 - $63.06 $4.45 Million - $6.28 Million
-99,588 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$46.31 - $62.7 $4.61 Million - $6.24 Million
99,588 New
99,588 $5.04 Million
Q3 2020

Nov 16, 2020

SELL
$42.19 - $69.61 $234,956 - $387,658
-5,569 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$27.55 - $43.28 $153,425 - $241,026
5,569 New
5,569 $233,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.